Enfusion Financials
| ENFN Stock | USD 10.10 0.21 2.12% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.97 | 3.4395 |
|
|
Investors should never underestimate Enfusion's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Enfusion's cash flow, debt, and profitability to make informed and accurate decisions about investing in Enfusion.
Net Income |
|
Enfusion | Select Account or Indicator |
Understanding current and past Enfusion Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Enfusion's financial statements are interrelated, with each one affecting the others. For example, an increase in Enfusion's assets may result in an increase in income on the income statement.
Enfusion Earnings Geography
Enfusion Stock Summary
Enfusion competes with ON24, Paycor HCM, E2open Parent, Braze, and Freshworks. Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois. Enfusion Inc operates under SoftwareApplication classification in the United States and is traded on New York Stock Exchange. It employs 892 people.Specialization | Information Technology, Software - Application |
| Instrument | USA Stock View All |
| Exchange | New York Stock Exchange |
| ISIN | US2928121043 |
| CUSIP | 292812104 |
| Location | Illinois; U.S.A |
| Business Address | 125 South Clark |
| Sector | Software |
| Industry | Information Technology |
| Benchmark | Dow Jones Industrial |
| Website | www.enfusion.com |
| Phone | 312 253 9800 |
| Currency | USD - US Dollar |
Enfusion Key Financial Ratios
| Return On Equity | 0.0548 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.06 % | ||||
| Price To Sales | 4.78 X | ||||
| Revenue | 174.53 M |
Enfusion Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Enfusion's current stock value. Our valuation model uses many indicators to compare Enfusion value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Enfusion competition to find correlations between indicators driving Enfusion's intrinsic value. More Info.Enfusion is rated # 2 in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers reporting about 1.08 of Return On Asset per Return On Equity. At this time, Enfusion's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Enfusion's earnings, one of the primary drivers of an investment's value.Enfusion's Earnings Breakdown by Geography
Enfusion Systematic Risk
Enfusion's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Enfusion volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Enfusion correlated with the market. If Beta is less than 0 Enfusion generally moves in the opposite direction as compared to the market. If Enfusion Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Enfusion is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Enfusion is generally in the same direction as the market. If Beta > 1 Enfusion moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Enfusion Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Enfusion's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Enfusion growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Enfusion November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Enfusion help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Enfusion. We use our internally-developed statistical techniques to arrive at the intrinsic value of Enfusion based on widely used predictive technical indicators. In general, we focus on analyzing Enfusion Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Enfusion's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.65 | |||
| Information Ratio | 0.1156 | |||
| Maximum Drawdown | 10.11 | |||
| Value At Risk | (2.77) | |||
| Potential Upside | 3.93 |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.27) | Earnings Share 0.04 | Revenue Per Share 2.155 | Quarterly Revenue Growth 0.154 | Return On Assets 0.0592 |
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.